More than $2.9 million raised through Spark Good "Round Up" program for Operation Homefront. SAN ANTONIO, Feb. 9, 2026 /PRNewswire/ -- Operation Homefront, a leading national military nonprofit, announced today that Walmart's Spark Good program raised more than $2.9 million, including a...

LONDON, Feb. 9, 2026 /PRNewswire/ -- The global sports nutrition market is projected to be valued at US$27.3 billion in 2025 and is forecast to reach US$45.9 billion by 2032, representing a CAGR of 7.7% between 2025 and 2032. This expansion is driven by rising participation in sports and...

USD 7.4 billion revenue and double-digit profit growth underline strength of Healthcare and Insurance across global and local markets EBITDA of USD 1.3 billion, up 16.1% year on year Total assets reached USD 15.6 billion, with c.50% of the asset base now outside the UAE PureHealth...

USD 7.4 billion revenue and double-digit profit growth underline strength of Healthcare and Insurance across global and local markets EBITDA of USD 1.3 billion, up 16.1% year on year Total assets reached USD 15.6 billion, with c.50% of the asset base now outside the UAE PureHealth...

STOCKHOLM, Feb. 9, 2026 /PRNewswire/ -- Diamyd Medical today announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for a patent covering the intralymphatic administration of retogatein (rhGAD65) with alum for the prevention and treatment of...

STOCKHOLM, Feb. 9, 2026 /PRNewswire/ -- Diamyd Medical today announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for a patent covering the intralymphatic administration of retogatein (rhGAD65) with alum for the prevention and treatment of...

The efficacy of the TGF-β×PD-L1 bispecific antibody (BsAb) is not promising clinically. The authors here develop a Y101S, an antibody-drug conjugate targeting TGF-β, PD-L1, and STING, which manifests superior anti-tumor efficacy in preclinical models with the mechanism of enhanced CXCL16 mediated cytotoxic CXCR6+ T cells recruitment.

Expanded solid-state characterization services now deliver advanced X-ray diffraction, expert interpretation, and regulatory-ready data for market authorization and patents. WEST LAFAYETTE, Ind., Feb. 9, 2026 /PRNewswire/ -- Improved Pharma is pleased to announce the expansion of its...

NEW YORK, Feb. 9, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) between August 3, 2023 and December 26, 2025. A class action lawsuit has...

Breast cancer (BC) is the most frequent malignant tumor among women worldwide [1]. Surgery, radiotherapy, and systemic treatments are used as a multimodality approach in standard-of-care treatments. Postoperative radiotherapy (PORT) is indicated for the majority of patients affected by non-metastatic BC after conservative surgery or, based on therisk of recurrence, mastectomy [2]. PORT has been demonstrated to improve tumor local control +/- patients’ overall survival [3]. Among the different techniques, external beam radiotherapy (EBRT) performed with photons represents the most widely used approach.

HONG KONG, Feb. 9, 2026 /PRNewswire/ -- Peijia Medical Limited (HKEX: 9996) today announced that it has formally submitted the European Union Medical Device Regulation (EU MDR) CE Mark registration application for its internally developed GeminiOne Transcatheter Edge-to-Edge Repair (TEER)...

STOCKHOLM, Feb. 9, 2026 /PRNewswire/ -- BioArctic AB's (publ) (NASDAQ: BIOA B (Stockholm: BIOA B) partner Eisai announced today that the Biologics License Application (BLA) for the treatment of early Alzheimer's disease with Leqembi (lecanemab), using a subcutaneous autoinjector (SC-AI),...

STOCKHOLM, Feb. 9, 2026 /PRNewswire/ -- BioArctic AB's (publ) (NASDAQ: BIOA B (Stockholm: BIOA B) partner Eisai announced today that the Biologics License Application (BLA) for the treatment of early Alzheimer's disease with Leqembi (lecanemab), using a subcutaneous autoinjector (SC-AI),...

HONG KONG, Feb. 9, 2026 /PRNewswire/ -- Peijia Medical Limited (HKEX: 9996) today announced that it has formally submitted the European Union Medical Device Regulation (EU MDR) CE Mark registration application for its internally developed GeminiOne Transcatheter Edge-to-Edge Repair (TEER)...

Los eventos 'Salute to Service' y 'Strong Youth, Strong Communities' traen leyendas del fútbol americano profesional a Sacramento y West Sacramento SACRAMENTO, California, 8 de febrero de 2026 /PRNewswire-HISPANIC PR WIRE/ -- El miércoles 4 de febrero, Health Net, uno de los planes de...

CHONGQING, China, Feb. 9, 2026 /PRNewswire/ -- SWS Medical will participate in the Dubai World Health (WHX) Expo for the seventh consecutive year. From February 9-12, the SWS team will exhibit at Booth N°37.D70-01, engaging with industry leaders, partners, and clients. The company...

SHANGHAI, Feb. 8, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), announced it has been awarded a Platinum Medal by the EcoVadis Sustainability Rating, marking the third year the company has received the rating's highest level of recognition. EcoVadis is among the world's most trusted and...

SAN FRANCISCO and SUZHOU, China, Feb. 8, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncologic, autoimmune, cardiovascular and...

The content on this site is intended for healthcare professionals. All content on this site: Copyright © 2026 Elsevier Inc., its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.

Ovarian cancer is the seventh most common malignant neoplasm in women and the eighth leading cause of mortality among them. Depending on the components of the ovary from which it originates, ovarian cancer is classified as epithelial, stromal or germinal, with epithelial ovarian cancer being the most common subtype [1].

The podcast, featuring health care experts from across the country, offers practical guidance through straight talk to empower consumers to make more informed decisions about their own care. TAMPA, Fla., Feb. 7, 2026 /PRNewswire/ -- Tampa General Hospital (TGH) today announced the launch...

NEW YORK, Feb. 6, 2026 /PRNewswire/ -- Today, MAHA Center Inc. announced it will release a Super Bowl advertisement featuring Mike Tyson, simultaneously launching a national campaign for Americans to Eat Real Food. In the ad, Mike describes his sister's death from obesity and his own...

Nature Immunology, Published online: 06 February 2026; doi:10.1038/s41590-026-02449-yPublisher Correction: The differentiation and function of heterogeneous thymic dendritic cell subsets require signals provided by distinct thymocyte cell types

The organizations delivered high-quality, affordable, value-based care for members and patients and worked to improve the health of the communities they serve. OAKLAND, Calif., Feb. 6, 2026 /PRNewswire/ -- Kaiser Foundation Health Plan, Inc., Kaiser Foundation Hospitals, Risant Health,...

WASHINGTON, Feb. 5, 2026 /PRNewswire/ -- The National Association of Benefits and Insurance Professionals (NABIP) today applauded Congress for approving a government spending package that includes several critical healthcare provisions NABIP has long championed to increase transparency,...